paperKB
coga / coga-kb
Help
Sign in

naltrexone protective_against binge drinking

Subject
naltrexone
Relation
protective_against
Object
binge drinking
p-value
0.02
Evidence from: primary | all sources

Evidence (5 sources)

Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018) PMID:30167705 cited
During the four‑month treatment period, 68.2% of naltrexone‑treated patients had ≥1 binge drinking day compared to 71.4% of ...
confidence: 0.70
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018) PMID:30167705 cited
meta-analysis supports naltrexone’s efficacy in reducing ... return to binge drinking (RD= −0.09)
confidence: 0.95
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018) PMID:30167705 cited
68.2% of naltrexone‑treated patients had ≥1 binge drinking day compared to 71.4% of placebo patients (P=0.02).
confidence: 0.96
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018) PMID:30167705 cited
The likelihood of no binge drinking increased ... to 75.0% ... in the oral naltrexone group and ... to 77.8% ... in the long-acting naltrexone group.
confidence: 0.95
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018) PMID:30167705 cited
use of naltrexone to reduce the risk of binge drinking
confidence: 0.97